The 52%energy of the solar radiation is contributed by near-infrared radiation(NIR,780-2500 nm).Therefore,the material design for the energy-saving smart window,which can effectively shield NIR and has acceptable visi...The 52%energy of the solar radiation is contributed by near-infrared radiation(NIR,780-2500 nm).Therefore,the material design for the energy-saving smart window,which can effectively shield NIR and has acceptable visible transmittance,is vital to save the energy consumed on the temperature control system.It is important to find a non-toxic stable material with excellent NIR-shielding ability and acceptable visible transmittance.The systematic first-principles study on Li_(x)Sn_(y)WO_(3)(x=0,0.33,0.66,and y=0,0.33)exhibits that the chemical stability is a positive correlation with the doping concentration.After doping,the Fermi-energy upshifts into the conduction band,and the material shows metal-like characteristics.Therefore,these structures Li_(x)Sn_(y)WO_(3)(except the structure with x=0.33 and y=0)show pronounced improvement of NIR shielding ability.Our results indicate that when x=0 and y=0.33,the material exhibits the strongest NIR-shielding ability,satisfying chemical stability,wide NIR-shielding range(780-2500 nm),and acceptable visible transmittance.This work provides a good choice for experimental study on NIR shielding material for the energy-saving window.展开更多
BACKGROUND Pancreas transplantation(PT)has emerged as a critical therapeutic intervention for patients with type 1 diabetes mellitus(T1DM).This procedure restores neuroendocrine communication,which is essential for op...BACKGROUND Pancreas transplantation(PT)has emerged as a critical therapeutic intervention for patients with type 1 diabetes mellitus(T1DM).This procedure restores neuroendocrine communication,which is essential for optimal pancreatic function and insulin regulation.The recovery process involves multiple phases,including neural regeneration,revascularization,and the re-establishment of synaptic connections,all of which contribute to the restoration of both endocrine and neurological functions.AIM To systematically examine the mechanisms underlying neurological recovery following PT,to explore the role of endocrine factors in restoring neurofunctional integrity,and to evaluate the impact of immunosuppressive therapy on nerve regeneration and its clinical outcomes.METHODS A comprehensive literature search was conducted across international databases such as PubMed,Web of Science,and Cochrane Library to identify studies addressing PT,neurological recovery,and endocrine regulation.Inclusion criteria encompassed randomized controlled trials,cohort studies,and systematic reviews.The review focused on the neurogenic mechanisms activated post-transplantation,the effect of glycemic control on nerve repair,and the implications of immunosuppressive drugs on the process of neurological recovery.RESULTS A total of 211 articles were initially identified through the literature search across international databases such as PubMed,Web of Science,and Cochrane Library.Following a detailed evaluation and the application of inclusion and exclusion criteria,56 articles were further reviewed,and 8 were selected for the final analysis.Additionally,a comprehensive patent search yielded 168 patents,out of which 6 were selected for further examination.These sources,including both journal literature and patents,offer significant insights into the mechanisms of neurological recovery and endocrine function following PT,with an emphasis on nerve regeneration,glycemic control,and the impact of immunosuppressive therapy.CONCLUSION PT represents a promising intervention for restoring both endocrine and neurological functions in patients with T1DM.Glycemic control,neural regeneration,and the restoration of neuroendocrine signaling are key components of successful recovery.While the procedure yields substantial improvements in nerve function,challenges persist,particularly in patients with long-standing diabetes or severe neuropathy.The dual impact of immunosuppressive drugs on immune suppression and neurotoxicity necessitates careful management.Future research should focus on refining immunosuppressive protocols and exploring advanced therapeutic options,including stem cell-based interventions,to enhance neural regeneration and further improve clinical outcomes.展开更多
With the rising global obesity rates,particularly in industrialized nations,obesity has become an increasingly significant public health concern.This review analyzes 132 relevant studies published between 2020 and 202...With the rising global obesity rates,particularly in industrialized nations,obesity has become an increasingly significant public health concern.This review analyzes 132 relevant studies published between 2020 and 2025,with a focus on the role of gut-derived substances in regulating obesity.These include gut hormones[such as glucagon-like peptide-1(GLP-1),glucose-dependent insulinotropic polypeptide(GIP),peptide YY,cholecystokinin,and ghrelin],microbial metabolites[such as short-chain fatty acids(SCFA)and indole-3-propionic acid(IPA)],and neurotransmitters(such as serotonin and dopamine).The findings suggest that gut hormones play a crucial role in regulating appetite,glucose metabolism,and energy expenditure,and their dysregulation is closely linked to the development of obesity.Moreover,microbial metabolites like SCFA and IPA are strongly associated with metabolic health and significantly influence obesity-related mechanisms.This review also explores emerging therapeutic strategies,including GLP-1 receptor agonists,dual GLP-1/GIP receptor agonists,modulation of the gut microbiota,and fecal microbiota transplantation,all of which demonstrate promising potential in obesity management.However,challenges remain in optimizing these interventions,mitigating adverse effects,and establishing regulatory standards for microbiota-based therapies.Future research should aim to develop personalized,multi-targeted approaches to more effectively combat obesity and its associated metabolic disorders.展开更多
文摘The 52%energy of the solar radiation is contributed by near-infrared radiation(NIR,780-2500 nm).Therefore,the material design for the energy-saving smart window,which can effectively shield NIR and has acceptable visible transmittance,is vital to save the energy consumed on the temperature control system.It is important to find a non-toxic stable material with excellent NIR-shielding ability and acceptable visible transmittance.The systematic first-principles study on Li_(x)Sn_(y)WO_(3)(x=0,0.33,0.66,and y=0,0.33)exhibits that the chemical stability is a positive correlation with the doping concentration.After doping,the Fermi-energy upshifts into the conduction band,and the material shows metal-like characteristics.Therefore,these structures Li_(x)Sn_(y)WO_(3)(except the structure with x=0.33 and y=0)show pronounced improvement of NIR shielding ability.Our results indicate that when x=0 and y=0.33,the material exhibits the strongest NIR-shielding ability,satisfying chemical stability,wide NIR-shielding range(780-2500 nm),and acceptable visible transmittance.This work provides a good choice for experimental study on NIR shielding material for the energy-saving window.
基金Supported by National Natural Science Foundation of China,No.82305376The Project of Supporting Young Scientific and Technological Talents in Jiangsu Province in 2024,No.JSTJ-2024-380.
文摘BACKGROUND Pancreas transplantation(PT)has emerged as a critical therapeutic intervention for patients with type 1 diabetes mellitus(T1DM).This procedure restores neuroendocrine communication,which is essential for optimal pancreatic function and insulin regulation.The recovery process involves multiple phases,including neural regeneration,revascularization,and the re-establishment of synaptic connections,all of which contribute to the restoration of both endocrine and neurological functions.AIM To systematically examine the mechanisms underlying neurological recovery following PT,to explore the role of endocrine factors in restoring neurofunctional integrity,and to evaluate the impact of immunosuppressive therapy on nerve regeneration and its clinical outcomes.METHODS A comprehensive literature search was conducted across international databases such as PubMed,Web of Science,and Cochrane Library to identify studies addressing PT,neurological recovery,and endocrine regulation.Inclusion criteria encompassed randomized controlled trials,cohort studies,and systematic reviews.The review focused on the neurogenic mechanisms activated post-transplantation,the effect of glycemic control on nerve repair,and the implications of immunosuppressive drugs on the process of neurological recovery.RESULTS A total of 211 articles were initially identified through the literature search across international databases such as PubMed,Web of Science,and Cochrane Library.Following a detailed evaluation and the application of inclusion and exclusion criteria,56 articles were further reviewed,and 8 were selected for the final analysis.Additionally,a comprehensive patent search yielded 168 patents,out of which 6 were selected for further examination.These sources,including both journal literature and patents,offer significant insights into the mechanisms of neurological recovery and endocrine function following PT,with an emphasis on nerve regeneration,glycemic control,and the impact of immunosuppressive therapy.CONCLUSION PT represents a promising intervention for restoring both endocrine and neurological functions in patients with T1DM.Glycemic control,neural regeneration,and the restoration of neuroendocrine signaling are key components of successful recovery.While the procedure yields substantial improvements in nerve function,challenges persist,particularly in patients with long-standing diabetes or severe neuropathy.The dual impact of immunosuppressive drugs on immune suppression and neurotoxicity necessitates careful management.Future research should focus on refining immunosuppressive protocols and exploring advanced therapeutic options,including stem cell-based interventions,to enhance neural regeneration and further improve clinical outcomes.
基金Supported by The National Natural Science Foundation,Youth Science Fund Project,No.82305376The Youth Talent Support Project of the China Acupuncture and Moxibustion Association,No.2024-2026ZGZJXH-QNRC005+1 种基金The 2024 Jiangsu Province Youth Science and Technology Talent Support Project,No.JSTJ-2024-3802025 Jiangsu Provincial Science and Technology Think Tank Program Project,No.JSKX0125035.
文摘With the rising global obesity rates,particularly in industrialized nations,obesity has become an increasingly significant public health concern.This review analyzes 132 relevant studies published between 2020 and 2025,with a focus on the role of gut-derived substances in regulating obesity.These include gut hormones[such as glucagon-like peptide-1(GLP-1),glucose-dependent insulinotropic polypeptide(GIP),peptide YY,cholecystokinin,and ghrelin],microbial metabolites[such as short-chain fatty acids(SCFA)and indole-3-propionic acid(IPA)],and neurotransmitters(such as serotonin and dopamine).The findings suggest that gut hormones play a crucial role in regulating appetite,glucose metabolism,and energy expenditure,and their dysregulation is closely linked to the development of obesity.Moreover,microbial metabolites like SCFA and IPA are strongly associated with metabolic health and significantly influence obesity-related mechanisms.This review also explores emerging therapeutic strategies,including GLP-1 receptor agonists,dual GLP-1/GIP receptor agonists,modulation of the gut microbiota,and fecal microbiota transplantation,all of which demonstrate promising potential in obesity management.However,challenges remain in optimizing these interventions,mitigating adverse effects,and establishing regulatory standards for microbiota-based therapies.Future research should aim to develop personalized,multi-targeted approaches to more effectively combat obesity and its associated metabolic disorders.
